These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 6097596)

  • 1. Propagation of large quantities of poliovirus in human lymphoblastoid cells grown in a serum-free medium.
    Bjare U
    J Virol Methods; 1984 Nov; 9(3):259-68. PubMed ID: 6097596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum free cultivation of lymphoid cells for virus and interferon production.
    Bjare U; Räbb I
    Dev Biol Stand; 1985; 60():349-54. PubMed ID: 2995174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Replication of poliovirus and measles virus in cultures of human lymphoblastoid and of Burkitt lymphoma cell lines.
    Fagraeus A; Böttiger M; Heller L; Norrby E
    Arch Virol; 1981; 69(3-4):229-37. PubMed ID: 6271103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary results on the use of human diploid fibroblasts for inactivated polio virus vaccine production.
    Larsson B; Litwin J
    Dev Biol Stand; 1980; 46():241-7. PubMed ID: 6245000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production of high titer attenuated poliovirus strains on the serum-free PER.C6(®) cell culture platform for the generation of safe and affordable next generation IPV.
    Sanders BP; Oakes Ide L; van Hoek V; Liu Y; Marissen W; Minor PD; Wimmer E; Schuitemaker H; Custers JH; Macadam A; Cello J; Edo-Matas D
    Vaccine; 2015 Nov; 33(48):6611-6. PubMed ID: 26529068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PER.C6(®) cells as a serum-free suspension cell platform for the production of high titer poliovirus: a potential low cost of goods option for world supply of inactivated poliovirus vaccine.
    Sanders BP; Edo-Matas D; Custers JH; Koldijk MH; Klaren V; Turk M; Luitjens A; Bakker WA; Uytdehaag F; Goudsmit J; Lewis JA; Schuitemaker H
    Vaccine; 2013 Jan; 31(5):850-6. PubMed ID: 23123018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protein-free culture of Vero cells: a substrate for replication of human pathogenic viruses.
    Cinatl J; Cinatl J; Rabenau H; Rapp J; Kornhuber B; Doerr HW
    Cell Biol Int; 1993 Sep; 17(9):885-95. PubMed ID: 8220316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Replication of poliovirus (LSc 2 ab) in perfused cultures of MRC-5 diploid cells.
    Mann GF; de Mucha J
    Dev Biol Stand; 1976 Dec 13-15; 37():255-8. PubMed ID: 201522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monkey kidney cell growth optimization and poliovirus propagation in microcarrier culture.
    Mered B; Albrecht P; Hopps HE; Petricciani JC; Salk J
    Dev Biol Stand; 1981; 47():41-53. PubMed ID: 6262160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virus production with a newly developed microcarrier system.
    Giard DJ; Thilly WG; Wang DI; Levine DW
    Appl Environ Microbiol; 1977 Dec; 34(6):668-72. PubMed ID: 202193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Growth of poliovirus using alginate entrapped-anchorage dependent Vero cells.
    Trépanier P; Dugré R; Alain R; Lapierre J
    Cytotechnology; 1990 Nov; 4(3):261-9. PubMed ID: 1369301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Production of a highly cytopathic HIV-1 isolate from a human mucosal epithelial cell line cultured on microcarrier beads in serum-free medium.
    Yahi N; Baghdiguian S; Fantini J
    In Vitro Cell Dev Biol Anim; 1995 Jan; 31(1):62-6. PubMed ID: 7535637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suspension culture of HeLa cells in protein-free medium: sensitivity to human pathogenic viruses.
    Cinatl J; Cinatl J; Wichelhaus T; Weber B; Rabenau H; Gümbel HO; Kornhuber B; Doerr HW
    Intervirology; 1994; 37(6):361-6. PubMed ID: 8586536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved poliovirus D-antigen yields by application of different Vero cell cultivation methods.
    Thomassen YE; Rubingh O; Wijffels RH; van der Pol LA; Bakker WA
    Vaccine; 2014 May; 32(24):2782-8. PubMed ID: 24583004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suspension-Vero cell cultures as a platform for viral vaccine production.
    Paillet C; Forno G; Kratje R; Etcheverrigaray M
    Vaccine; 2009 Oct; 27(46):6464-7. PubMed ID: 19559123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative sensitivity of three cell substrates to the Sabin poliovirus strains.
    Kado G
    Dev Biol Stand; 1976 Dec 13-15; 37():261-4. PubMed ID: 201523
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparison of methods for the large-scale culture of cells and viruses].
    Grachev VP; Zaval'nyĭ MA; Popova VD; Khanina MK; Mironova LL
    Vopr Virusol; 1983; 28(4):44-9. PubMed ID: 6314668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth and poliovirus production of Vero cells on a novel microcarrier with artificial cell adhesive protein under serum-free conditions.
    Kurokawa M; Sato S
    J Biosci Bioeng; 2011 May; 111(5):600-4. PubMed ID: 21262586
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Influenza virus reproduction in the MDCK cells adapted to growth in serum-free Hybris-2 medium].
    Podcherniaeva RIa; Baklanova OV; Glushchenko LA; Isaeva EI; Chestkov VV; Tabakov VIu; Mikhaĭlova GR
    Vopr Virusol; 2010; 55(5):47-9. PubMed ID: 21260998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Poliovirus: generation, quantification, propagation, purification, and storage.
    Burrill CP; Strings VR; Andino R
    Curr Protoc Microbiol; 2013; Chapter 15():15H.1.1-15H.1.27. PubMed ID: 23686830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.